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Abstract
Background: Recurrent pregnancy loss (RPL) which is generally known as >3 consecutive pregnancy losses before 20 weeks’
gestation is seen in 0.5-2% of women
Objective: To evaluate the association of  parental and fetal chromosomal abnormalities with recurrent pregnancy loss in
our area and to analyze the frequency of  three types of  hereditary thrombophilia’s; (MTHFR C677T polymorphisms, FV
Leiden G1691A mutation and Prothrombin (factor II) G20210A mutation) in these female patients.
Methods: The present case-control retrospective study was performed between February 2007 and December 2011 on 495
couples, who had two or more consecutive pregnancy losses before 20 weeks’ gestation. We used conventional cytogenetic
analysis and polymerase chain reaction–restriction fragment length polymorphism.
Results: Parental chromosomal abnormality was detected in 28 cases (2.8% of all cases, 5.7% of the couples) most of which
(92.9%) were structural abnormalities. All of the structural abnormalities were balanced chromosomal translocations.
Chromosomal analysis performed from the abortion materials detected a major chromosomal abnormality in 31.9% of the
cases. The most frequently observed alteration in the hereditary thrombophilia genes was heterozygote mutation for the
MTHFR C677T polymorphisms (n=55).
Conclusion: Balanced translocations are the most commonly detected chromosomal abnormalities in couples being evaluated
for recurrent pregnancy loss and these patients are the best candidates for offering prenatal genetic diagnosis by the help of
which there is a possibility of obtaining a better reproductive outcome.
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Introduction
Recurrent pregnancy loss (RPL) which is generally
known as >3 consecutive pregnancy losses before
20 weeks’ gestation is seen in 0.5-2% of women.1,2
It is defined by American Society of Reproductive
Medicine (ASRM) as two or more failed
pregnancies.3 Several etiological factors like
endocrinological problems, uterine structural or
chromosomal anomalies and prothrombotic
conditions can be the cause in some of  these cases.
However, about 40-60% of the RPL cases are
idiopathic4. Chromosomal abnormalities, which are
the most common causes of sporadic early
pregnancy losses, are also reported to be responsible
from an important proportion of  recurrent losses.5,6
It has been a very common practice to blame
the hereditary thrombophilias which include Factor
V Leiden mutation, Prothrombin G20210A gene
mutation, Protein S deficiency, Protein C deficiency,
Antithrombin deficiency, and
methylenetetrahydrofolate reductase (MTHFR)
mutations in the pathogenesis of RPL . There are
contradictory studies in the literature that either do
or do not support the possible role of hereditary
thrombophilias in the etiology of  RPL.7,11
In the present study we evaluated the
association of parental and fetal chromosomal
abnormalities with RPL. Also, we analyzed the
frequency of three types of hereditary
thrombophilia’s; (MTHFR C677T polymorphisms,
FV Leiden G1691A mutation and Prothrombin
G20210A mutation) in female patients.
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Methods
Subjects
The present case-control retrospective study was
performed between February 2007 and December
2011. The study population consisted of 495 couples,
who had two or more consecutive pregnancy losses
before 20 weeks’ gestation. Age of the female
patients at their last pregnancy loss was recorded.
Couples in whom the woman’s history revealed
thromboembolism or systemic disease were
excluded from the study.  The Ethics Committee at
Suleymaniye Maternity Hospital for Research and
Training approved the use of  the clinical information
and the collection of  samples for research purposes.
Standard cytogenetic analysis
In order to reveal the karyotype of the patients, 72-
hour culturing was performed using peripheral blood
lymphocytes induced with phytohaemagglutinin
(PHA). Metaphase preparates obtained after
culturing were stained using the trypsin Giemsa
banding method (GTG). Small tissue specimens
obtained from the abortion materials were cultured
in three separate flasks. In cases in which mosaic
karyotype was identified in the abortion material,
maternal tissue contamination was excluded by
analysis of the materials with small tandem repeat
(STR) markers (16 region). Beginning from the 7th
day, f lasks were controlled in terms of  cell
proliferation and contamination, and at around the
13th to 14th days cultures with adequate colonies were
harvested. CTG banding was performed by
conventional cytogenetic methods in all metaphases
obtained from all 3 cultures. In metaphases that were
suspicious for polymorphisms, C banding was also
performed.  The results of  the cytogenetic analysis
were examined in 3 groups as: 1) Numerical
chromosomal abnormalities 2) Structural
chromosomal abnormalities 3) Polymorphisms.
PCR method
Factor V Leiden, Prothrombin G20210A and
MTHFR C677T gene polymorphisms were analyzed
by polymerase chain reaction–restriction fragment
length polymorphism (PCR-RFLP). The enzymes
used for the mutation analyses of Factor V Leiden,
Prothrombin G20210A and MTHFR C677T were
Mnl I, Hind III, Hinf  I, respectively. The fragments
were visualized by ethidium bromide under UV
transilluminator.
Results
A total of  495 couples were included in the study.
Mean age of the female patients was 30.6 years
(range: 19-44). Parental chromosome analysis was
performed in all of  the 495 couples. Among these
990 subjects, a major chromosomal abnormality was
detected in 28 cases (2.8% of all cases, 5.7% of the
couples) (table 1). 16 (57.1%) of  the abnormalities
were in females, and, 12 (42.9) of  the abnormalities
were in males.
Table 1: Spectrum of  major chromosomal
abnormalities detected from chromosome
analysis of  495 couples performed for the
investigation of the etiology of recurrent
pregnancy loss.





























There were no couples in whom a chromosomal
abnormality was detected in both the male and the
female partner. Of  these, 2 (7.1%) were numeric
and 26 (92.9%) were structural abnormalities. All of
the structural chromosomal abnormalities detected
in the parents were balanced translocations.
Polymorphisms were detected in 316 (31.9%) of
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the 990 subjects (table 2). The most commonly
detected polymorphism was an increase in the
centromeric heterochromatin region of the 1st
chromosome.
Table 2: Polymorphic chromosomal variants
detected in couples with a history of  recurrent
pregnancy loss


















Yqh+ or Yqh- 76
Total 316
Chromosomal analysis from the abortion material
was performed in 250 cases, but cell culture was
successful in 135 of these. A major chromosomal
abnormality was detected in 43 (31.9%) cases, of
which 39 (90.7%) were numeric and 4 (9.3%) were
structural (table 3).  Polymorphisms were detected
in 5 (3.7%) of  the 135 cases.
Four hundred ninety five females that were
included in the study were tested for three types of
hereditary thrombophilia’s; MTHFR C677T
polymorphisms, FV Leiden G1691A mutation and
Prothrombin G20210A mutation. Among these, 414
of the women did not carry any of these mutations
while any abnormality which could be at least a
heterozygote mutation in any of these genes was
detected in 81 (16.4%) cases (table 4). The most
frequently observed abnormality in this group was
heterozygote mutation for the MTHFR
polymorphisms (n=55).
Table 3: Chromosomal abnormalities detected from chromosome analysis of  the abortion materials
of 250 cases. (Cell culture was successful in 135 cases, unsuccessful in 115 cases)
Numerical (n=39) Structural (n=4) Polymorphism (n=5)
47,XY,+5 (n=1) 46,XX,der(7)t(3;7)(p21.3;q35) 1qh+
47,XY,+8 (n=1) 46,XY,der(14)t(8;14)(p21;q32)mat 46,XX,inv(9)(p11q13)   
47,XY,+12 (n=1) 46,XY,r(13;14),+13 46,XX,inv(9)(p11q13)   
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Table 4: Genotypes of  the hereditary
thrombophilia genes in 81 patients
Discussion
Parental chromosomal abnormalities are detected
in about 2-8% of couples with recurrent
miscarriages.12 Several types of  genetic problems like
parental structural chromosomal abnormalities and
recurrent aneuploidies may be associated with
recurrent miscarriage. Balanced chromosomal
rearrangements are found in 2-5% of these couples,
and among these balanced translocations are the most
frequent abnormalities13. In our study, parental
chromosomal abnormality was detected in 2.8% of
all cases and 5.7% of  the couples. As expected, most
of  these (92.9%) were structural abnormalities and
all of  the structural abnormalities were balanced
chromosomal translocations. As we know, these
patients are the best candidates for offering prenatal
genetic diagnosis (PGD) by the help of which better
reproductive outcomes can be obtained14 although
the data about latter aspect of PGD is still
insufficient.15 PGD, which has some technical
limitations currently;16 is difficult and it requires in
vitro fertilization with or without intracytoplasmic
sperm injection which is expensive and may not be
convenient in all patients.
Chromosome analysis from the abortion
material helps us to detect whether any type of
chromosomal abnormality in the fetus is the reason
of  the abortion. We know from the previous studies
that chromosomal abnormalities are responsible
from about half  of  early miscarriages. For example
Zhang et al. investigated chorionic villi of 252 cases
of missed abortion and detected chromosomal
abnormality in 58.09% of  the cases (81 were trisomy,
29 were monosomy X and 17 were polyploidy).17
Similarly, Kwinecka-Dmitriew et al. studied the
incidence of  chromosomal abnormalities in
abortions and detected chromosomal abnormalities
in 37.5% (45/120) of  the cases (trisomy, triploidy
and monosomy X in decreasing frequency).18 The
incidence was 42.4% (25/59) in the first miscarriages
and 32.8% (20/61) in recurrent miscarriages. The
higher incidence of  the chromosomal abnormalities
in the first miscarriages than in recurrent ones were
interpreted as that recurrent miscarriages were less
likely caused by genetic factors. In our study,
chromosomal analysis performed from the abortion
materials of patients with RPL detected a major
chromosomal abnormality in 31.9% of  the cases,
which is in accordance with the literature. Obtaining
such a result form the abortion material can be
helpful in the genetic counseling of the patient and
couples will be informed about the recurrence risk
of  the detected genetic abnormality in the subsequent
pregnancies. The result can narrow the list of  work-
up needed for the patient.
In our study, cell proliferation did not occur
in the culture of abortion materials of 115 cases
(46%) and our culture success rate was 54%. The
culture success rates reported in the literature before
are very much higher than that of  us. For example
Be et al. reported a culture success rate of 95.1% 19,
and Hogge et al. reported a rate of  94.6%.20 Our
lower culture success rate may be due to possible
contamination of the samples during collection.
Sterile collection of the abortion material is important
as mentioned firstly by Stephenson et al., they
mentioned that a higher culture success rate can be
obtained by obtaining the material with dilatation
and curettage rather than collection of spontaneously
expelled tissue.21
Small structural chromosomal abnormalities
like short tandem repeats, single nucleotide
polymorphisms and copy number variants are
known as polymorphisms. These generally have no
clinical significance and are known to be responsible
from most of  the genetic variations in populations.
Recent studies have mentioned the possible
association of polymorphisms with reproductive
failure and recurrent spontaneous miscarriages.22 In
our study, we detected polymorphisms in 31.9% of
the subjects and in 3.7% of  the abortion samples.
The most commonly detected polymorphism in our
subjects was an increase in the centromeric
heterochromatin region of the 1st chromosome.
Thrombophilia disorders can lead to
disordered placental perfusion because of
thrombosis in the spiral arteries and intervillous space








FVL Heterozygous 5 (6,2)
FII Heterozygous 4 (4,9%)
FII Heterozygous /MTHFR 
Heterozygous
2 (2,5%)
MTHFR Heterozygous in addition 
to a structural chromosomal 
abnormality
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late fetal loss and preeclampsia. But the association
of  hereditary thrombophilia’s with early pregnancy
loss is not clarified yet. The roles of hereditary
thrombophilia’s in RPL’s have been extensively
studied and a large amount of contradictory literature
about this issue has accumulated. For example, Karata
et al. recently compared the prevalence of factor V
G1691A Leiden, Prothrombin G20210A, and
MTHFR C677T mutations in patients with recurrent
pregnancy losses (RPL) with that of the control
group.7 They found that a significant difference
existed only for the homozygous and heterozygous
mutations of MTHFR C677T mutations, which
seemed to have an association with RPL. Neither
homozygous nor heterozygous mutations of
Prothrombin G20210A and factor V G1691A were
different between the groups. Another similar study
of Habibovic et al. found that the frequency of
factor V Leiden, Prothrombin G20210A but also
MTHFR C677T mutations were similar in both the
study and control group.8 In our study, among 495
women tested for polymorphisms in these genes,
an abnormality was detected in 81 cases, the most
frequent of which was MTHFR heterozygote
mutation. The frequency of MTHFR heterozygote
mutation in the normal control subjects was found
to be 38.1%. For example, Karata et al.7recently
compared the prevalence of factor V G1691A and
MTHFR C677T mutations in patients with RPL with
that of  the of  11.1% (55/495) among our subjects.
Conclusion
RPL is a condition which has both psychological
and economical adverse effects both for the couples
and experts dealing with these patients. Highlighting
the real cause will be beneficial for both. Detection
of an underlying clinically insignificant thrombophilic
disorder may not be so beneficial for the time being,
since the benefits of  anticoagulant treatment in terms
of pregnancy outcome and the safety of such a
treatment for the patient has not been proved
yet.11,23,24 The most important issue with hereditary
thrombophilia’s is the prevention of  maternal
thrombosis and indication for anticoagulant
treatments should be made according to the
expected risk of thrombosis associated with the
specific disorder.  But, finding a cytogenetic
abnormality in an aborted fetus or in any of  the
parents may decrease the further investigations that
the couples have to undergo. This will be both time
and cost saving in evaluation process of  these patients.
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